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Background: Clinical studies of myocardial protection rarely identify differences in
hard clinical outcomes after surgery, either early or late, because most trials lack
sufficient statistical power to deal with low-frequency events.
Methods: Prospectively collected data concerning all isolated coronary bypass
operations from November 1989 to February 2000 were analyzed to determine the
effects of cold blood cardioplegia and warm or tepid blood cardioplegia on early and
late outcomes after surgery. Warm blood cardioplegia was used in 4532 patients,
whereas cold blood cardioplegia was used in 1532. The allocation of patients to
receive warm blood cardioplegia and cold blood cardioplegia was random in 749
cases and according to surgeon preference in the remainder. Most patients in the
cold blood cardioplegia group had surgery earlier in the time course of the study,
and most in the warm blood cardioplegia group underwent surgery later.
Results: Perioperative death, myocardial infarction, and death or myocardial infarc-
tion were all more common in the cold blood cardioplegia group than in the warm
blood cardioplegia group (death 2.5% vs 1.6%, P  .027, adjusted odds ratio 1.45,
95% confidence interval 0.95-2.22, P  .09; myocardial infarction 5.4% vs 2.4%,
P  .0001, adjusted odds ratio 1.86, 95% confidence interval 1.36-2.53, P  .0001;
death or myocardial infarction 7.3% vs. 3.8%, P  .0001, adjusted odds ratio 1.70,
95% confidence interval 1.30-2.21, P .0001). Actuarial survival at 60 months was
91.1% 1.4% in the warm blood cardioplegia group and 89.9% 1.3% in the cold
blood cardioplegia group (P  .09), whereas freedom from death or myocardial
infarction was 84.7%  1.8% and 83.2%  1.6%, respectively (P  .16). In
multivariate models, cold blood cardioplegia was associated with poorer survival
(risk ratio 1.30, 95% confidence interval 0.96-1.75, P  .09) and freedom from any
death or late myocardial infarction (risk ratio 1.93, 95% confidence interval 1.56-
2.39, P  .0001).
Conclusions: In 6064 patients undergoing isolated coronary artery bypass grafting,
warm or tepid blood cardioplegia may be associated with better early and late
event-free survivals than is cold cardioplegia.
The Warm Heart Trial (WHT) was a randomized trial of 1732 patientscomparing cold versus warm cardioplegia that demonstrated thatalthough there were significant decreases in low-output syndrome(9.3% vs 6.1%, P  .01) and enzymatically identified myocardialinfarction (MI, 17.3% vs 12.3%, P  .01), there was only a non-significant improvement in early mortality (2.5% vs 1.4%, P 
0.12).1 The early benefits of improved myocardial protection may not be observed
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in gross measures of such outcomes after cardiac surgery as
mortality or MI. By lengthening the time of observation and
changing the time horizon from a short-term perioperative
period to a long-term or late follow-up period, it may be
possible to distinguish differences in mortality and morbid-
ity resulting from subtle improvements in perioperative
myocardial protection conferred by the use of warm cardio-
plegia. In particular, with a subpopulation of the WHT we
have shown that patients who survive perioperative events
have poorer long-term survival than do patients in whom
there are no perioperative complications.2 It is often the case
that clinical trials of cardioplegia fail to demonstrate differ-
ences in important but uncommon outcomes, such as mor-
tality. Retrospective cohort studies may be useful in these
situations because of the larger sample size and statistical
power that increased size confers. The objective of this
study was to determine differences in early and late out-
comes after isolated coronary artery bypass surgery, com-
paring cold and warm cardioplegia.
Methods
Patient Population and Data Collection
All patients undergoing isolated coronary artery bypass grafting at
Sunnybrook and Women’s College Health Sciences Centre be-
tween November 1989 and February 2000 were identified from a
hospital based research database and included in the study. A total
of 6064 patients were included; 4532 of these patients received
warm or tepid cardioplegia and 1532 patients received cold car-
dioplegia. Of these 6064 patients, 762 were enrolled in the WHT,1
and their cardioplegia regimens were determined by random allo-
cation (warm or tepid blood cardioplegia n  378, cold blood
cardioplegia n  384). The cardioplegia received in the remaining
cases was according to surgeon preference.
Data on more than 200 demographic, anatomic, preoperative,
perioperative, and postoperative variables were collected prospec-
tively on all patients undergoing surgery at Sunnybrook and Wom-
en’s College Health Sciences Centre by chart review during the
hospital stay and completed shortly after discharge from hospital.
Follow-up data were collected during routine follow-up care. All
patients were seen at 3 months and 1 year and were requested to
return on a voluntary basis at 3, 5, 7.5, and 10 years after surgery.
This information is supplemented with information from referring
physicians’ offices.
Surgical Management
The surgical procedure has been described in detail elsewhere.1,3
In brief, cardiopulmonary bypass was established with a single
2-staged right atrial cannula and ascending aortic perfusion can-
nula and ascending aortic cardioplegia cannula and vent line.
Cardiopulmonary bypass included membrane oxygenators, arterial
line filters, nonpulsatile flows of 2.4 L  min1  m2, mean arterial
pressure of 50 to 80 mm Hg, moderate hemodilution with a
TABLE 1. Patient characteristics
Warm Cold P value
Age (y)
Mean  SD 62.8 9.7 62.4 9.5 .1165
70 23.3% 21.3% .105
Female 20.2% 17.8% .04
Congestive heart failure 4.2% 3.5% .26
Canadian Cardiovascular
Society class 3-4
78.8% 74.8% .001
Diabetes mellitus 25.3% 21.7% .004
Hypertension 49.5% 45.8% .013
Elevated cholesterol 61.4% 54.8% .0001
Renal disease 2.9% 3.0% .862
Chronic obstructive pulmonary
disease
5.0% 5.4% .591
Peripheral vascular or
cerebrovascular disease
16.6% 13.8% .011
Reoperation 2.1% 4.6% .0001
Urgent operation 38.0% 30.6% .0001
Preoperative IABP 3.0% 2.7% .54
Left ventricular ejection
fraction 40%
19.3% 14.6% .0001
Left main disease 17.2% 18.5% .26
Extent of involvement .4806
Single-vessel disease 1.2% 1.1%
Double-vessel disease 2.2% 2.7%
Triple-vessel disease 96.7% 96.3%
Recent preoperative MI 12.3% 7.8% .0001
Recent percutaneous
transluminal angioplasty
7.5% 4.8% .0002
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hematocrit value greater than 20%, and alpha-stat acid-base bal-
ance. In the warm or tepid blood cardioplegia group, the systemic
temperature was maintained at 33°C to 37°C, and the blood
cardioplegia was delivered at a temperature of 37°C. In the tepid
cardioplegia group, the systemic temperature was permitted to drift
passively during the operation to 32°C to 34°C. The temperature of
the cardioplegia was 28° to 30°C. In the cold cardioplegia group,
the systemic temperature was actively cooled to 25°C to 32°C, and
the blood cardioplegia was actively cooled to a temperature of 5°C
to 8°C. The blood cardioplegia was prepared by mixing oxygen-
ated blood with a crystalloid additive (Fremes solution) in a 4:1
ratio4 or an 8:1 ratio5 and was administered in an intermittent,
antegrade manner. Retrograde cardioplegia was used in 8.5% of
cases. The warm strategy was used exclusively in the study pa-
tients. The tepid strategy was gradually adopted after the comple-
tion of the WHT on December 31, 1992.
Study End Points
Study outcomes are reported for the early and the late phases of
postoperative recovery. The primary early outcome measure of this
study was the combined end point of perioperative death or MI.
Other outcomes were early mortality and MI considered sepa-
rately, postoperative stroke, postoperative intra-aortic balloon
pump (IABP) insertion, low-output syndrome, and blood transfu-
sion. MI was defined as the emergence of new Q waves after the
operation, or a peak creatine kinase isoenzyme MB level greater
than 50 IU/L that represented more than 7% of total creatine
kinase. Low output syndrome was defined as the requirement of
inotropic or IABP support for a period longer than 60 minutes after
surgery to maintain a cardiac index greater than 2.2 L  min1 
m2 and a systolic blood pressure greater than 90 mm Hg in
association with a wedge pressure greater than 18 mm Hg. Blood
transfusion was considered to be the transfusion of any blood
product.
The primary late outcome measures of this study were late
survival and freedom from death or MI determined late after
operation. Perioperative deaths contributed toward estimates of
late survival and event-free status. However, perioperative MI did
not contribute toward estimates of late event-free status.
Statistical Analysis
Continuous data are expressed as mean SD, and categoric data are
given as frequency or percentage. Baseline comparisons were
made with a 2-tailed Student t tests for continuous variables and
the Fisher exact test for categoric variables. Early outcomes were
compared by stepwise logistic regression. The area under the
receiver operating characteristic curve was used to evaluate model
discrimination, and the calibration was assessed with the Hosmer-
Lemeshow goodness-of-fit test.6 Late events were compared by
survival analysis methods, with covariate adjustment performed by
Cox proportional hazards model. All statistical analyses were
performed with the SAS statistical package for the personal com-
puter (version 8; SAS Institute, Inc, Cary, NC).
Results
The clinical characteristics of the cardioplegia groups are
shown in Table 1. Patients in the warm or tepid blood
cardioplegia group were generally at higher predicted pre-
operative risk than were patients in the cold blood cardio-
plegia group because of a greater number of female patients
and higher prevalences of diabetes, hypertension, peripheral
or cerebral vascular disease, severe angina, and depressed
ventricular function. Patients in the warm or tepid blood
cardioplegia group were more likely to undergo urgent
operation for unstable angina, and a greater percentage had
recent MI. In contrast, reoperation was more common in the
cold blood cardioplegia group. There were similar preva-
lences in the two groups of older patients, patients with
renal disease, and patients with left main disease.
In total, there were 6 patients who had both initial and
repeated isolated coronary bypass operations in this study.
All 6 patients had warm blood cardioplegia at the time of
the initial operation, and 2 of these patients had cold blood
cardioplegia at the reoperation. However, all these patients
were treated as part of the warm or tepid blood cardioplegia
group for the purpose of analysis.
The early results, unadjusted for other covariates, are
presented in Table 2. There was a decreased incidence of the
primary early outcome of death or MI (P  .0001) with
warm or tepid blood cardioplegia as compared with cold
blood cardioplegia. In addition, the incidence of death (P 
.027) and MI (P  .0001) considered separately and of
IABP insertion (P  .0001), low-output syndrome (P 
.0001), and blood transfusion (P  .0001) was decreased in
the warm or tepid blood cardioplegia group. The incidence
of stroke was similar in the two groups.
The multivariate predictors of early death or MI are
presented in Figure 1. The main predictors of death or MI
after surgery were older age, hypertension, worse New York
Heart Association status, poorer left ventricular function,
reoperation, preoperative IABP, and use of endarterectomy.
The use of any internal thoracic artery graft was protective
against early death or MI. This analysis also showed that
cold blood cardioplegia was associated with a greater ad-
justed risk of death or MI relative to warm or tepid blood
cardioplegia, with an odds ratio of 1.70 (95% confidence
interval [CI] 1.3-2.2, P  .0001). Separate logistic regres-
sion analyses were also performed for the outcomes of death
or MI considered separately and for stroke, IABP insertion,
and low-output syndrome (Table 3). Cold blood cardiople-
TABLE 2. Early results
Warm Cold P value
Death or MI 3.8% 7.3% .0001
Death 1.6% 2.5% .027
Postoperative MI 2.4% 5.4% .0001
Cerebrovascular accident 1.9% 2.3% .339
Postoperative IABP 2.7% 5.4% .0001
Low-output syndrome 9.7% 16.0% .0001
Blood transfusion 53.2% 61.3% .0001
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gia cardioplegia was associated with greater adjusted risks
of death (P  .09), MI (P  .0001), IABP insertion (P 
.0002), and low-output syndrome (P  .0006) but not of
stroke.
An important potential confounder of the effect of car-
dioplegia temperature was the date of surgery. Figure 2
depicts the use of warm or tepid blood cardioplegia and cold
cardioplegia during the study period. This figure shows a
steady decrease with time in the number of patients in
whom cold cardioplegia was used, from a high of 529
cases (67.6%) in 1989 through 1991 to the recent low of
116 cases (6.3%) in 1997 through 2000. The logistic
regression analyses were therefore repeated for the end
point of death or MI with date included as an additional
covariate expressed as a dichotomous variable, before
versus after January 1, 1995. The magnitude of the effect
of cold blood cardioplegia cardioplegia when controlled
for era was not significantly different from that shown in
Table 3. Late outcomes after surgery were also investi-
gated. Actuarial survival is shown in Figure 3, and free-
dom from death or MI is shown in Figure 4. Neither the
actuarial survival (P  .09) nor the event-free survival
(P  .16) was significantly greater in the warm or tepid
blood cardioplegia cohort in unadjusted analyses. Results
of the Cox regression analyses of late death and of death
or MI are shown in Tables 4 and 5, respectively. Figure
5 shows the results of Cox regression analysis on late
death or MI. Cold blood cardioplegia was not a signifi-
cant predictor of late mortality (P  .09) but was a
Figure 1. Predictors of early death or MI. Bar lengths represent odds ratios, and error bars represent 95% CI. Use
of internal thoracic artery (ITA) was protective of perioperative events, whereas all other factors were predictive
of worse outcome. Adjusted odds ratio for cold cardioplegia was 1.724. REDO, Reoperation; PREIABP, preoperative
IABP; ENDART, endarterectomy; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association
functional class.
TABLE 3. Logistic regression: Early results
Cold versus warm
P valueOdds ratio 95% CI
Death or MI 1.70 1.30-2.21 .0001
Death 1.45 0.95-2.23 .09
MI 1.86 1.36-2.53 .0001
Cerebrovascular accident 1.38 0.89-2.00 .15
Postoperative IABP 1.77 1.31-2.39 .0002
Low output syndrome 1.71 1.42-2.05 .0006
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significant predictor of late death or MI. These analyses were
repeated with the confounder of era of operation. Cold cardio-
plegia remained a significant predictor of death or MI in Cox
regression analyses after controlling for date of operation.
Discussion
Buckberg and colleagues7 introduced warm blood cardio-
plegia in 1977. It was used as a method to decrease the
reperfusion injury that occurred after crossclamp removal
and was delivered as a terminal hot shot given approxi-
mately 3 to 5 minutes before aortic crossclamp removal.8
The concept of warm blood cardioplegia induction was
introduced in 1983 with the realization that the initial dose
of cardioplegia to a chronically ischemic and substrate
depleted heart represented the first phase of reperfusion. It
was shown that warm blood induction resulted in active
resuscitation and improved tolerance of the myocardium to
the subsequent ischemic period.9 Subsequently, multidose
warm cardioplegia has been used throughout the induction,
maintenance, and reperfusion phase of the ischemic period.
Warm blood cardioplegia has been shown to result in im-
proved metabolic and functional recovery of the myocar-
dium in many experimental models. There have been many
randomized control trials of warm blood cardiople-
gia.1,3,10-20 Investigators at the universities of Toronto and
Emory conducted the two largest clinical trials of warm
versus cold cardioplegia. The Emory University trial en-
rolled 1001 patients and was stopped prematurely as a result
of increased incidence of adverse neurologic events in the
warm cardioplegia group. It was reported that 4.5% of
patients in the warm group had adverse neurologic events
(defined as either a new stroke or encephalopathy), versus
1.4% in the cold cardioplegia group. Other important find-
ings were that there were no significant differences in mor-
tality (1.0% with warm or tepid blood cardioplegia vs 1.6%
with cold blood cardioplegia), Q-wave MI (1.4% for warm
or tepid blood cardioplegia vs 0.8% for cold blood cardio-
plegia), or need for IABP (1.4% for warm or tepid blood
cardioplegia vs 2.0% for cold blood cardioplegia). The
WHT was published in 1994 and was one of the largest
cardiac surgical randomized control trials ever performed.
There were no significant differences in the primary end
points of death or Q-wave MI. However, there were signif-
icantly fewer cases of enzymatically defined MI (12.3% vs
17.3%, P  .01) and low-output syndrome (6.1% vs 9.3%,
P  .01) with warm or tepid blood cardioplegia, and peri-
operative mortality was nonsignificantly reduced (1.4% vs
2.5%, P  .12). This study was undertaken to investigate
the effect of warm cardioplegia on early and late death and
MI.
Figure 2. Cardioplegia use with time. Bars represent number of cases performed in indicated period. Use of cold
cardioplegia decreased from a high of 67% in early years to 6% in late years.
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The effect of cold cardioplegia on late survival is shown
in Table 4. The significant predictors of late mortality were
reoperation (hazard ratio 3.36, 95% CI 2.07-5.48), renal
disease (hazard ratio 2.55, 95% CI 1.59-4.08), vascular
disease (hazard ratio 2.29, 95% CI 1.66-3.13), left ventric-
ular ejection fraction less than 40% (hazard ratio 2.28, 95%
CI 1.67-3.12), and age older than 70 years (hazard ratio
1.70, 95% CI 1.26-2.30). The use of cold cardioplegia was
not significantly associated with poorer long-term survival
(hazard ratio 1.30, 95% CI 0.96-1.75). The use of an internal
thoracic artery graft was associated with improved late
survival (hazard ratio 0.74, 95% CI 0.48-0.94). Thus it
would appear that the use of warm/tepid cardioplegia, al-
though tending toward improved late survival, did not exert
a statistically significant effect.
The main findings of this study were that cold cardio-
plegia is associated with poor short-term freedom from
death or MI and poorer long-term freedom from death or
MI. In the short-term, cold cardioplegia was associated with
death or MI in both univariate and multivariate analyses.
There was an absolute risk increase of 3.5% with the use of
cold cardioplegia (P  .0001). The factor-adjusted odds
ratio was 1.70 for the composite end point of death or MI
(95% CI 1.30-2.21, P  .0001). This also translated into
worse values for freedom from death or MI with cold
cardioplegia. A hazard ratio of 1.93 (95% CI 1.56-2.39, P
.0001) was observed with cold cardioplegia when perioper-
ative MIs were excluded from the analysis. A more robust
measure of coronary artery bypass grafting outcomes is any
death or MI. Indeed, when perioperative deaths from MI
were included in the analysis of late outcomes, cold cardio-
plegia remained a significant predictor of late morbidity.
Cold cardioplegia was associated with a hazard ratio of 1.65
(95% CI 1.31-2.07, P  .0001). After controlling for era of
procedure and retrograde cardioplegia delivery, it remained
a significant predictor of poor outcome (hazard ratio 1.64,
95% CI 1.31-2.05, P  .0001).
The use of retrograde cardioplegia has been shown to be
of particular benefit in the setting of warm or tepid cardio-
plegia.21-24 It has been suggested that the use of normother-
mic cardioplegic solutions necessitates the use of retrograde
cardioplegia as a means of attaining continuous myocardial
perfusion.25 The use of retrograde cardioplegia in our study
was generally limited to patients perceived to be at higher
Figure 3. Late survival. Percentages alive at 0, 1, 2, 3, 4, 5, and 6 years are plotted according to cardioplegia
temperature used. Numbers across bottom are numbers of patients at risk for event at different periods. There was
no significant difference between cold and warm or tepid cardioplegia with respect to late survival according to
univariate analysis (P  .09).
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risk from surgery. These included more patients undergoing
urgent surgery with recent MI or increased incidence of
preoperative IABP insertion, patients with severely de-
pressed ventricular function or active congestive heart fail-
ure, or patients undergoing reoperation. There was no dif-
ference in the use of retrograde cardioplegia between cold
and warm or tepid strategies. In multivariate analyses, ret-
rograde administration was associated with worse long-term
outcomes even after controlling for the effects other risk
factors (hazard ratio 1.74, 95% CI 1.20-2.53). The risk of
retrograde cardioplegia is probably overestimated by the
presence of significant selection bias. Despite inclusion of
retrograde cardioplegia in the models for short-term and
long-term outcomes, cold cardioplegia remained an impor-
tant predictor of poorer result.
Since the advent of warm heart surgery, there has been
great concern regarding the potential increased incidence of
adverse perioperative neurologic outcomes with warm car-
dioplegia. Stroke is one of the most devastating complica-
Figure 4. Freedom from death or MI. Percentages alive at 0, 1, 2, 3, 4, 5, and 6 years are plotted according to
cardioplegia temperature used. Numbers across bottom are numbers of patients at risk for event at different
periods. There was no significant difference between cold and warm or tepid cardioplegia with respect to death
or MI according to univariate analysis (P  .16).
TABLE 4. Late mortality: Cox regression
Factor Risk ratio of death 95% CI
Reoperation 3.36 2.07-5.48
Renal disease 2.55 1.59-4.08
Vascular disease 2.29 1.66-3.13
Left ventricular ejection
fraction 40%
2.28 1.67-3.12
Older age 1.70 1.26-2.30
Cold cardioplegia 1.30 0.96-1.75
Left internal thoracic artery
use
0.74 0.48-0.94
TABLE 5. Late mortality or MI: Cox regression
Factor
Risk ratio of
death or MI 95% CI
Renal disease 2.53 1.65-3.87
Cold cardioplegia 1.93 1.56-2.39
Left ventricular ejection
fraction 40%
1.55 1.22-1.97
Endarterectomy 1.41 1.07-1.86
Vascular disease 1.37 1.07-1.75
Left internal thoracic artery use 0.64 0.46-0.87
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tions of cardiac surgery. Multivariate statistical analyses of
stroke after coronary artery bypass grafting have identified
several important risk factors, including older age, female
gender, renal insufficiency, the presence of cerebrovascular
or peripheral vascular disease, higher New York Heart
Association functional class, perioperative MI, and intraop-
erative detection of atheromatous debris in the aorta.26-36
Warm heart surgery, or the administration of warm cardio-
plegia with the maintenance of normothermia during car-
diopulmonary bypass, has also been suggested as another
risk factor for stroke.10,37,38 Despite the finding of the
Emory University trial investigators demonstrating an in-
creased incidence of stroke with warm cardioplegia, how-
ever, the WHT did not corroborate this finding. A substudy
of the trial examined neuropsychologic outcomes in these
patients and concluded that cognitive changes were similar
in the warm and cold cardioplegia groups.39 This new study
included more than 6000 patients undergoing coronary ar-
tery bypass grafting, and there were no differences in stroke
rate between the hypothermic and tepid or normothermic
strategies of cardiopulmonary bypass maintenance. The dif-
ferences between the rates of stroke in the warm cardiople-
gia groups from the Emory and University of Toronto trials
may be due to the strict adherence to systemic normother-
mia in the Atlanta study and the use of mild systemic
hypothermia and avoidance of hyperthermia during re-
warming.38
This study includes patients who were operated on over
the period of a decade. During this period there have been
great changes in the management of patients with cardio-
vascular disease, from both surgical and medical points of
view, that have had a large impact on the survival of these
patients. The positive interpretation of the results of the
WHT at our institution led to the increased acceptance of
warm or tepid blood cardioplegia as a strategy for myocar-
dial protection and may in large part explain the shift in
cardioplegia use from predominately cold blood cardiople-
gia in the earliest period to warm or tepid blood cardioplegia
in the most recent period (Figure 2). In the recent era,
patients being evaluated for operation have had higher bur-
dens of illness and greater risk profiles than in earlier
periods.40-42 Earlier studies from this institution also sug-
gested that adjusted perioperative event rates had declined.
We were therefore concerned that our conclusions regarding
Figure 5. Predictors of late death or MI. Bar lengths represent odds ratios, and error bars represent 95% CI. Hazard
ratios of statistically significant risk factors are shown. Greatest predictor of late death or MI was presence of
renal disease (RENAL), followed by cold blood cardioplegia (COLD, hazard ratio 1.93, 95% CI 1.56-2.39). Internal
thoracic artery (ITA) use was protective against late adverse outcome. VASCULAR, Cerebrovascular or peripheral
vascular disease; ENDART, endarterectomy; LVEF, left ventricular ejection fraction.
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warm cardioplegia were confounded by the year of surgery.
Cardioplegia temperature remained a significant variable
with minimal change in the odds or hazard ratios in multi-
variate analyses of early and long-term results after control-
ling for the year of surgery.
Randomized controlled trials are the criterion standard of
evidence in clinical research. A well-designed study should
eliminate problems of bias that can occur with other types of
studies.43,44 However, randomized controlled trials often
have strict entry and exclusion criteria that limit their ap-
plicability to the general practice of coronary bypass sur-
gery. In addition, they often fail to demonstrate differences
in uncommon but important clinical events because of in-
sufficient power of the study design.43 To circumvent the
power problem of a randomized control trial, retrospective
cohort studies may be used. If the information to conduct
these studies is retrieved from administrative or research
databases, generally there are enough subjects to provide
sufficient statistical power to be able to demonstrate small
differences in important clinical variables.
Cohort studies are prone, however, to unmeasured bias.
An important systematic bias may exist in this study with
respect to the late attrition in warm or tepid blood cardio-
plegia and cold blood cardioplegia groups. Most patients in
the cold blood cardioplegia group underwent surgery in the
earlier period, and this may have resulted in either better or
poorer attrition rates than in the warm or tepid blood car-
dioplegia group. During the time course of the study, the
quality of follow-up care may have changed, and this would
systematically affect the two groups differently because the
distribution of patients into the treatment groups was not
constant with time. Despite the previously listed advantages
of performing a cohort study, the possibility of unmeasured
bias influencing the results of this analysis is not precluded.
In conclusion, this large retrospective cohort analysis of
cold cardioplegia versus warm or tepid cardioplegia dem-
onstrates two facts. First, warm cardioplegia is safe for
patients undergoing coronary artery bypass grafting. In par-
ticular, it is not associated with an increased incidence of
adverse neurologic outcomes. Second, this study demon-
strates that warm or tepid cardioplegia may be associated
with better short-term and long-term freedoms from cardiac
morbidity and mortality.
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Notice of correction
In the November 2002 issue of the Journal, in the article by Menicanti and Di Donato titled “The
Dor Procedure: What Has Changed After Fifteen Years of Clinical Practice?” (2002;124:886-90), an
error was made. On line 2 in the “Conclusion” section (page 890), the word “posterior” should be
changed to “anterior.”
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